Humes Jennifer 4
4 · Roivant Sciences Ltd. · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
Roivant (ROIV) CAO Jennifer Humes Sells 13,538 Shares
What Happened Jennifer Humes, Chief Accounting Officer of Roivant Sciences Ltd. (ROIV), reported the sale of 13,538 common shares on April 8, 2026. The transaction generated approximately $384,073 in proceeds at a weighted-average price of $28.37 per share. The filing lists the sale as open market or private sale (code S).
Key Details
- Transaction date: April 8, 2026; Form 4 filed April 10, 2026 (Accession No. 0001140361-26-014301). Filing appears to be within the normal two-business-day reporting window.
- Price: weighted average $28.37; individual trade prices ranged from $28.36 to $28.38 per footnote.
- Shares sold: 13,538; total proceeds ≈ $384,073.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnote: the reported price is a weighted average; reporting person can provide a breakdown of the number of shares sold at each price upon request.
Context This was a sale (often routine insider selling) and does not, by itself, indicate the insider’s view of the company’s prospects. No option exercise, gift, or tax-withholding event is noted in the provided details.
Insider Transaction Report
Form 4
Humes Jennifer
Chief Accounting Officer
Transactions
- Sale
Common Shares
[F1]2026-04-08$28.37/sh−13,538$384,073→ 84,191 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.36 to $28.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Jennifer Humes|2026-04-10